ABSI — Absci Corporation stock price and chart

Share this page

ABSI

$8.25-7.09%

as of close, Oct 16, 2026

☾ AH $8.25 -7.09%

Absci CorporationStock · HealthcareRussell 2000 0.05%US Stock Market 0.002%Russell 3000 0.002%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Jul 26, 2021

VolumeEEEE

20212022202420252026

5.010.015.020.025.030.0050.0M$8.25

2026-10-16

Price$8.25

MA20$9.04

MA50$7.30

Vol6.9M

What would $1,000 invested in ABSI be worth today? →

ABSI returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $8.25
YTD price return: +136.39%
YTD total return: +136.39%
Next earnings: Nov 12, 2026 · Before open
Market cap: 1.3B2021-09 1.1B2026-10 1.3B+20.6% over the window
Enterprise value: 1.1B
Shares outstanding: 157.5M2020-12 17.9M2026-06 157.5M+780.3% over the window
52W low: $2.24
52W high: $12.06
From 52W high: -31.56%
From 52W low: +268.30%
52W range: 61%

Volume

Rel volume: 0.87×
30D volume: 4.1M
30D $ vol: 39M

Fundamentals

Sales (ttm): 1.6M2020-12 4.8M2026-06 1.6M-67.3% over the window
Sales/share: $0.012020-12 $0.272026-06 $0.01-96.3% over the window
EPS (ttm): -$0.802020-12 -$3.192026-06 -$0.80-74.9% over the window
FCF (ttm): -109M2020-12 -13.2M2026-06 -109M+728.6% over the window
FCF/share: -$0.692020-12 -$0.742026-06 -$0.69-5.9% over the window
Book value/share: $1.562020-12 -$5.002026-06 $1.56-131.3% over the window
Net margin: -7756.37%2020-12 -300.3%2026-06 -7756.4%+2483.1% over the window
ROE: -49.19%2021-12 -27.6%2026-06 -49.2%+78.4% over the window
ROA: -45.02%2020-12 -16.2%2026-06 -45.0%+177.8% over the window
Current ratio: 10.632020-12 7.252026-06 10.63+46.5% over the window

Growth (CAGR, ttm) · 10Y

Sales: -62.30%2025-06-30 → 2026-06-304.1M → 1.6M (-62.3% total)-43.29%2023-06-30 → 2026-06-308.6M → 1.6M (-81.8% total)-18.43%2020-12-31 → 2026-06-304.8M → 1.6M (-67.3% total)n/a
Shares: +23.44%2025-06-30 → 2026-06-30127.6M → 157.5M (+23.4% total)+19.31%2023-06-30 → 2026-06-3092.7M → 157.5M (+69.9% total)+11.22%2021-06-30 → 2026-06-3092.6M → 157.5M (+70.1% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: -69.46%2025-06-30 → 2026-06-30$0.03 → $0.01 (-69.4% total)-52.47%2023-06-30 → 2026-06-30$0.09 → $0.01 (-89.3% total)-45.09%2020-12-31 → 2026-06-30$0.27 → $0.01 (-96.3% total)n/a
Book value/share: +15.04%2025-06-30 → 2026-06-30$1.36 → $1.56 (+15.0% total)-12.37%2023-06-30 → 2026-06-30$2.32 → $1.56 (-32.7% total)n/an/a
Price: +69.47%2025-10-16 → 2026-10-16$4.87 → $8.25 (+69.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+79.33%2023-10-16 → 2026-10-16$1.43 → $8.25 (+476.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.94%2021-10-15 → 2026-10-16$10.63 → $8.25 (-22.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +69.47%2025-10-16 → 2026-10-16$4.87 → $8.25 (+69.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+79.33%2023-10-16 → 2026-10-16$1.43 → $8.25 (+476.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.94%2021-10-15 → 2026-10-16$10.63 → $8.25 (-22.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -10.3×2021-09 -75.032026-10 -10.73-85.7% over the window
Fwd P/E: -15.0×
P/S (ttm)Market cap ÷ TTM revenue.: 832.2×2021-09 225.282026-10 832.25+269.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.3×2021-09 2.782026-10 5.28+90.2% over the window
EV/Sales (ttm): 706.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -8.39%2021-12 -13.0%2026-06 -6.0%-54.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-03-31) ÷ shares_at(2025-03-31) = 1 − 155.9M ÷ 127.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -22.24%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-22.24%) + dividends paid over that year ($0) ÷ market_cap_at(2025-03-31) ($320.2M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -22.24%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-170.2M) ÷ today's market cap ($1.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -13.10%2021-12 -27.7%2026-06 -9.3%-66.3% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-170.2M + TTM dividends $0) ÷ today's market cap ($1.3B). Same caveat as the cash buyback yield.: -13.10%2021-12 -27.7%2026-06 -9.3%-66.3% over the window

Vs own 10Y history

P/S: 95th
P/B: 93rd

Bar = where today’s multiple sits in ABSI’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-7.09%

-18.80%

+2.61%

+0.24%

YTD

+136.39%

+69.40%

-22.39%

Financial statements

Open full ABSI financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

ABSI — Absci Corporation price, chart and key statistics